BIOFORCE NANOSCIENCES HOLDINGS, INC. Quarterly Debt-to-equity in % from Q2 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bioforce Nanosciences Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q2 2019 to Q3 2024.
  • Bioforce Nanosciences Holdings, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -100 %, unchanged year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -100 0 0% Sep 30, 2024
Q2 2024 -100 +0.02 +0.02% Jun 30, 2024
Q1 2024 -100 +0.18 +0.18% Mar 31, 2024
Q4 2023 -100 +0.43 +0.43% Dec 31, 2023
Q3 2023 -100 +0.72 +0.72% Sep 30, 2023
Q2 2023 -100 +1.54 +1.52% Jun 30, 2023
Q1 2023 -100 +2.17 +2.12% Mar 31, 2023
Q4 2022 -100 +3.11 +3% Dec 31, 2022
Q3 2022 -101 +4.9 +4.64% Sep 30, 2022
Q2 2022 -102 +6.45 +5.97% Jun 30, 2022
Q1 2022 -102 +10.3 +9.11% Mar 31, 2022
Q4 2021 -104 +20.9 +16.8% Dec 31, 2021
Q3 2021 -106 +58.2 +35.5% Sep 30, 2021
Q2 2021 -108 +1.24K +92% Jun 30, 2021
Q1 2021 -113 -158 -350% Mar 31, 2021
Q4 2020 -125 -141 -866% Dec 31, 2020
Q3 2020 -164 -178 -1267% Sep 30, 2020
Q2 2020 -1.35K -1.37K -7868% Jun 30, 2020
Q1 2020 45 Mar 31, 2020
Q4 2019 16.3 Dec 31, 2019
Q3 2019 14 Sep 30, 2019
Q2 2019 17.4 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.